Global Balloon Valvuloplasty Devices Market Size Study & Forecast, By Type (Aortic Valvuloplasty, Pulmonary Valvuloplasty, Others) By Age Group (Pediatric, Adults), By End User (Hospitals & ASCs, Specialty Clinics, Others) and Regional Analysis, 2023-2030

Global Balloon Valvuloplasty Devices Market Size Study & Forecast, By Type (Aortic Valvuloplasty, Pulmonary Valvuloplasty, Others) By Age Group (Pediatric, Adults), By End User (Hospitals & ASCs, Specialty Clinics, Others) and Regional Analysis, 2023-2030

Global Balloon Valvuloplasty Devices Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Balloon valvuloplasty devices are medical instruments utilized in the treatment of heart valve diseases, particularly stenosis, which involves the narrowing of heart valves. These devices typically consist of a balloon catheter with an inflatable balloon at its tip. During the procedure, the balloon catheter is inserted into the affected valve through a blood vessel, commonly the femoral artery, and guided to the site of stenosis using imaging techniques such as fluoroscopy. Balloon valvuloplasty devices offer a minimally invasive alternative to surgical interventions for certain types of valve stenosis and are commonly used in the treatment of conditions such as mitral valve stenosis and pulmonary valve stenosis. The Balloon Valvuloplasty Devices market is expanding because of factors such as the increasing prevalence of heart valve diseases, rising adoption of transcatheter procedures, and favorable reimbursement policies for balloon valvuloplasty procedures.

The rising number of heart valve replacement procedures is a significant driver of growth in the Balloon Valvuloplasty Devices market. As the prevalence of heart valve diseases continues to increase globally, there is a growing demand for interventions to address these conditions. The Centers for Disease Control and Prevention (CDC) 2022 report states that 20.1 million persons aged 20 and older had coronary artery disease in 2020. Furthermore, the same report stated that every year about 805,000 Americans have a heart attack. While surgical valve replacement remains a common treatment option, an increasing number of patients, particularly those deemed high-risk or ineligible for surgery, are turning to less invasive alternatives such as transcatheter procedures. The National Library of Medicine announced in September 2022 that more than 200,000 heart valve replacement procedures are carried out annually worldwide, with an increase to 8,50,000 per year expected by 2050. Thus, the increasing prevalence of heart valve diseases is driving the market growth. In addition, advancements in balloon catheter technology and an expanding geriatric population are creating new opportunities for market growth. However, the risk of complications stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Balloon Valvuloplasty Devices Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. North America held the highest revenue share in the balloon valvuloplasty device market in 2022, a position it is expected to maintain throughout the forecast period. The region's market dominance is driven by factors such as the increasing elderly population and the growing prevalence of valvular heart disease, particularly in the United States. According to data from the Centers for Disease Control & Prevention, approximately 2.5% of the U.S. population is affected by valvular heart disease, with the condition disproportionately impacting the elderly demographic. Moreover, the expanding availability of medical reimbursements for balloon valvuloplasty devices, coupled with the rising adoption of minimally invasive surgical techniques and improvements in healthcare infrastructure, further bolster market growth in the region. These factors collectively contribute to the sustained demand for balloon valvuloplasty devices in North America. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the increasing aging population, rising burden of cardiovascular diseases, increasing awareness and education, and favorable government initiatives and reimbursement policies.

Major market players included in this report are:
Medtronic plc
Abbott Laboratories
Edwards Lifesciences Corporation
Boston Scientific Corporation
B. Braun Melsungen AG
Cardinal Health, Inc.
Cook Medical
JOTEC GmbH
MicroPort Scientific Corporation
Becton, Dickinson, and Company (BD)

Recent Developments in the Market:
 In December 2022, Abbott launched NavitorTM, a cutting-edge TAVI (transcatheter aortic valve implantation) system designed to address severe aortic stenosis in India, particularly among patients deemed to be at high or extreme surgical risk. Abbott's focus lies in advancing surgical therapies through innovations aimed at minimizing blood leakage around the valve.
 In September 2021, Abbott secured approval from the U.S. Food and Drug Administration (FDA) for Portico with FlexNav transcatheter aortic valve replacement (TAVR). This system is specifically tailored to treat patients afflicted with severe aortic stenosis, particularly those who face elevated risks associated with traditional open-heart surgery

Global Balloon Valvuloplasty Devices Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Type, Age Group, End User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Aortic Valvuloplasty
Pulmonary Valvuloplasty
Others
By Age Group:
Pediatric
Adults
By End User:
Hospitals & ASCs
Specialty Clinics
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.